The deal priced below last closing price of $4.50. Titan Partners is acting as sole book running manager for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVNO:
- enVVeno Medical offers to sell common stock
- enVVeno Medical appoints Sandy Prietto as VP, marketing
- enVVeno provides update on FDA premarket approval application for VenoValve
- enVVeno Medical expects capital to fund company through several milestones
- enVVeno Medical reports Q2 EPS (31c) vs. (58c) last year